Patents by Inventor James Blair West

James Blair West has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20190388395
    Abstract: Disclosed herein are processes for formulating a protein or a peptide for oral delivery, the process comprising the steps of: obtaining a powder containing the protein or peptide; obtaining an amount of an enteric polymer, wherein the enteric polymer is neutralized so that it is soluble in water; optionally obtaining at least one excipient; mixing the protein or peptide, the neutralized enteric polymer, and optionally the at least one excipient to obtain a First Dispersion; granulating the First Dispersion on a fluidized bed to obtain a Second Dispersion; whereby the protein or peptide in the Second Dispersion undergoes less than 50% proteolysis under gastric conditions.
    Type: Application
    Filed: August 6, 2019
    Publication date: December 26, 2019
    Applicant: BIODURO, LLC
    Inventors: James Blair WEST, Ke SHI
  • Publication number: 20190030003
    Abstract: Disclosed herein are processes for formulating a protein or a peptide for oral delivery, the process comprising the steps of: obtaining a powder containing the protein or peptide; obtaining an amount of an enteric polymer, wherein the enteric polymer is neutralized so that it is soluble in water; optionally obtaining at least one excipient; mixing the protein or peptide, the neutralized enteric polymer, and optionally the at least one excipient to obtain a First Dispersion; granulating the First Dispersion on a fluidized bed to obtain a Second Dispersion; whereby the protein or peptide in the Second Dispersion undergoes less than 50% proteolysis under gastric conditions.
    Type: Application
    Filed: March 21, 2018
    Publication date: January 31, 2019
    Applicant: BIODURO, LLC
    Inventors: James Blair WEST, Ke SHI
  • Patent number: 6984403
    Abstract: The present invention is related to an oral dosage form comprising an effective amount of an alkalizing agent and an azithromycin multiparticulate wherein said multiparticulate comprises azithromycin, a glyceride which comprises glyceryl monobehenate, glyceryl dibehenate, glyceryl tribehenate, or a mixture thereof and a poloxamer. Typically, the oral dosage form includes any suitable oral dosing means such as a powder for oral suspension, a unit dose packet or sachet, a tablet or a capsule.
    Type: Grant
    Filed: January 23, 2004
    Date of Patent: January 10, 2006
    Assignee: Pfizer Inc.
    Inventors: Timothy A. Hagen, Julian B. Lo, Avinash G. Thombre, Scott M. Herbig, Leah Elizabeth Appel, Marshall David Crew, Dwayne Thomas Friesen, David Keith Lyon, Scott Baldwin McCray, James Blair West
  • Publication number: 20040208926
    Abstract: Compositions of matter comprising sertraline and a solubilizing agent which increases the solubility of sertraline in aqueous chloride ion-containing use environments.
    Type: Application
    Filed: May 4, 2004
    Publication date: October 21, 2004
    Applicant: Pfizer Inc
    Inventors: Dwayne Thomas Friesen, Scott Max Herbig, Ravi Mysore Shanker, James Blair West
  • Patent number: 6517866
    Abstract: Sustained release dosage forms of sertraline which release sertraline at a rate between 1 mgA/hr and 40 mgA/hr. The dosage forms may exhibit an initial delay period during which sertraline is released at a rate less than 1 mgA/hr.
    Type: Grant
    Filed: September 7, 1999
    Date of Patent: February 11, 2003
    Assignee: Pfizer Inc.
    Inventors: Mary Tanya Am Ende, William John Curatolo, Hylar Lewis Friedman, Dwayne Thomas Friesen, Scott Max Herbig, Ravi Mysore Shankar, James Blair West